Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$442M |
| 2 |
Amazon
AMZN
|
+$347M |
| 3 |
Apple
AAPL
|
+$276M |
| 4 |
Intel
INTC
|
+$246M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$90M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$52.3M |
| 3 |
CPN
Calpine Corporation
CPN
|
+$45.5M |
| 4 |
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
|
+$40.3M |
| 5 |
LNCE
Snyders-Lance, Inc.
LNCE
|
+$40M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.82% |
| 2 | Financials | 16.57% |
| 3 | Healthcare | 13.16% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIA
2851
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $1.56M | ﹤0.01% |
26,369
+229
| +0.9% | +$12.2K |
|
2852
BlueLinx
BXC
$422M
| $1.56M | ﹤0.01% |
47,899
+10,189
| +27% | +$189K |
|
|
EVBN
2853
DELISTED
Evans Bancorp Inc
EVBN
| $1.56M | ﹤0.01% |
34,420
+770
| +2% | +$33.2K |
|
2854
NI Holdings
NODK
$310M
| $1.56M | ﹤0.01% |
93,189
+1,360
| +1% | +$22.6K |
|
|
XXII
2855
22nd Century Group
XXII
$1.38M
| – | – |
0
| – | – |
|
|
ALBO
2856
DELISTED
Albireo Pharma Inc
ALBO
| $1.55M | ﹤0.01% |
47,736
+15,884
| +50% | +$535K |
|
|
MXWL
2857
DELISTED
Maxwell Technologies Inc
MXWL
| $1.55M | ﹤0.01% |
261,433
+2,847
| +1% | +$16.6K |
|
2858
Unilever
UL
$137B
| $1.55M | ﹤0.01% |
24,751
+3,763
| +18% | +$229K |
|
|
CALA
2859
DELISTED
Calithera Biosciences, Inc
CALA
| $1.55M | ﹤0.01% |
12,282
-1,536
| -11% | -$240K |
|
2860
Graham Corp
GHM
$1.12B
| $1.54M | ﹤0.01% |
72,149
-2,143
| -3% | -$45.9K |
|
|
INAP
2861
DELISTED
Internap Corporation
INAP
| $1.54M | ﹤0.01% |
140,524
+1,968
| +1% | +$27.6K |
|
|
DRNA
2862
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.54M | ﹤0.01% |
161,577
+69,840
| +76% | +$753K |
|
2863
Descartes Systems
DSGX
$6.44B
| $1.54M | ﹤0.01% |
53,988
+1,015
| +2% | +$28.3K |
|
2864
First Business Financial Services
FBIZ
$587M
| $1.53M | ﹤0.01% |
61,026
+983
| +2% | +$23.7K |
|
2865
Timberland Bancorp
TSBK
$348M
| $1.53M | ﹤0.01% |
50,501
+592
| +1% | +$17K |
|
2866
Clear Channel Outdoor Holdings
CCO
$1.23B
| $1.53M | ﹤0.01% |
312,303
+22,177
| +8% | +$108K |
|
2867
Ocular Therapeutix
OCUL
$1.79B
| $1.53M | ﹤0.01% |
234,545
+58,535
| +33% | +$329K |
|
|
REIS
2868
DELISTED
Reis, Inc.
REIS
| $1.53M | ﹤0.01% |
71,173
+1,112
| +2% | +$22.6K |
|
|
AMBR
2869
DELISTED
Amber Road Inc
AMBR
| $1.52M | ﹤0.01% |
171,446
+16,476
| +11% | +$140K |
|
|
PRGX
2870
DELISTED
PRGX Global, Inc.
PRGX
| $1.52M | ﹤0.01% |
161,045
| – | – |
|
|
INSY
2871
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.51M | ﹤0.01% |
250,715
+5,050
| +2% | +$41.7K |
|
|
BBL
2872
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $1.51M | ﹤0.01% |
38,138
-15,364
| -29% | -$647K |
|
2873
AMES National
ATLO
$271M
| $1.51M | ﹤0.01% |
55,042
+646
| +1% | +$18K |
|
2874
INNOVATE Corp
VATE
$111M
| $1.51M | ﹤0.01% |
28,736
+537
| +2% | +$30.2K |
|
2875
Rocket Pharmaceuticals
RCKT
$340M
| $1.51M | ﹤0.01% |
+80,478
| New | +$1.31M |
|
Similar funds
Geode Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Geode Capital Management held 4,157 positions worth $307B, up 4.2% from $294B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Geode Capital Management deployed $15.6B of net new capital in Q1 2018, opening 131 new positions and adding to 2,872 existing holdings. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 899,850 shares worth $47.6M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Enbridge, an estimated $27.1M trimmed.
- Geode Capital Management's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 899,850 shares worth $47.6M.
- Geode Capital Management added most to Microsoft in Q1 2018, an estimated $442M increase.
- Geode Capital Management's biggest Q1 2018 reduction was Enbridge, cutting an estimated $27.1M.
- Geode Capital Management fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $90M.
- Geode Capital Management's ten largest holdings make up 17% of its $307B portfolio in Q1 2018.
- Geode Capital Management opened 131 new positions and closed 108 in Q1 2018.
- Geode Capital Management's portfolio value rose 4.2% quarter-over-quarter to $307B.
Based on Geode Capital Management's 13F filing for Q1 2018, filed 15 May 2018.